Reimagining Research Funding: Navigating the 15% Indirect Cost Cut in NIH Funding with Dr. Giovanni Filardo

Public health research is facing a major funding shift—but what does the 15% indirect cost cut mean for researchers, and how can we adapt?

In this episode, with Dr. Giovanni Filardo, a leading epidemiologist, health services researcher, and NIH/AHRQ-funded Principal Investigator, we will explore grant funding strategies, NIH and AHRQ grant survival tactics, and the power of collaboration in securing research funding.

Four Key Takeaways:

1. The Funding Shift: What does this 15% indirect cut mean for researchers, especially those early in their careers?

2. Survival Strategies: What strategies should researchers adopt to navigate this new funding landscape?

3. Collaborative Approaches: How important is collaboration now more than ever in sustaining funding and scaling impact?

4. The Bigger Picture: How do we reimagine funding models in public health research to ensure sustainability and innovation.

Whether you’re a public health professional, researcher, academic, grant writer, or funding strategist, this episode provides essential insights on navigating budget cuts, securing competitive grants, and sustaining impactful research.

Don’t forget to subscribe, rate, and share to stay ahead in the world of public health research, epidemiology, and healthcare funding!

#PublicHealth #ResearchFunding #NIHGrants #AHRQFunding #GrantWriting #AcademicResearch #Epidemiology #HealthcareResearch #FundingStrategy #Grants #ResearchInnovation #ScienceFunding #HealthPolicy #PublicHealthPodcast #FundingOpportunities

In this episode of "A USAID Insider’s Perspective on the Future of Global Health" on the What Is Public Health Podcast, we will dive deep into the shocking dismantling of U.S. Agency of International Development (USAID)—a move that is reshaping the future of public health.

Joined by Dr. Gretchen De Silva, former Senior Policy Advisor at USAID, we unpack how this pivotal shift will impact public health, international development, and the very future of aid. From the agency’s massive contributions to health crises, to the political decisions behind its dismantling, listen in for a candid conversation that challenges how we think about the intersection of policy, global impact, and future solutions.

To learn more about USAID:

⁠https://www.usaidstopwork.com/

Connect with Dr. Gretchen De Silva on LinkedIn

linkedin.com/in/gretchendesilva

Dr. Gretchen De Silva's Biography:

Gretchen De Silva was most recently a Senior Policy Advisor in the USAID Bureau for Global Health. In this role she managed formula@on and implementaion of development policies. She also coordinated all mulilateral engagements for the Bureau, such as with WHO, UNICEF, Gavi and others. In addition to her regular role, she was also serving as USAID’s Deputy Mpox Response Manager for the ongoing mpox clade 1 outbreak in central Africa. During her 6 years at USAID, Dr. De Silva managed a variety of USAID global health programming including activities in the areas of HIV, COVID-19, TB, global health security and more. Her time also included two years working for the USAID Mission in Mozambique to support laboratory health systems and leading on all the Mission’s COVID-19 vaccine programming. During her time as a AAAS Science & Technology Policy fellow she worked as a policy analyst in the Office of Foreign Assistance at the Department of State where she researched mid to long-term trends in foreign assistance and served on the Coronavirus Global Response Unit.

Before making her transition from academia to government thanks to AAAS, Dr. De Silva taught courses in biology and public health at the University of Maryland School of Public Health, George Washington School of Medicine, and Montgomery College. Her research included everything from an analysis of an HIV defaulter tracing program to investigating the molecular mechanisms of vaccinia virus cell entry. Dr. De Silva has a PhD from Johns Hopkins University in molecular biology and an MPH in infectious disease epidemiology from Columbia University.

Heart disease is still the #1 killer—but let’s be real, making heart-healthy choices isn’t as easy as doctors make it sound.

• Why is fast food cheaper than a salad?
• Who has time for the gym when life is already packed?
• And what’s actually new in heart health research?

In this episode, we break down the latest science on inflammation, the polypill, and cutting-edge treatments, plus real-life barriers to healthy habits. More importantly—we’re talking big-picture fixes: how public health can make heart-healthy living the default, not the struggle.

Ready for real solutions? Tune in now!